TYPE 2 DIABETES MELLITUS

This study checks if a new insulin pump (NMX8) and a continuous glucose monitor are safe for people with type 1 or type 2 diabetes. About 400 participants aged 7 to 85 will use the system for up to 90 days while tracking meals and exercise. The goal is to see how well the system …

This study looks at whether a structured clinical and medication management plan can improve heart health in adults with risk factors like high blood pressure, diabetes, and high cholesterol. Researchers will track 220 patients in a regular cardiology clinic to see if this approa…

This study tests whether personalized marketing and discounts in an online grocery store can encourage people with prediabetes or type 2 diabetes to buy more whole grains instead of refined grains. About 216 adults aged 45-70 from Pennsylvania who already shop online for grocerie…

This study is observing how well the diabetes drug luseogliflozin (Lusefi®) controls blood sugar and is tolerated by adults with type 2 diabetes in everyday medical practice. About 300 people will take part, and researchers will track changes in blood sugar levels, weight, and bl…

This study compares a continuous glucose monitor (CGM) to standard finger-prick testing in 270 adults with type 1 or type 2 diabetes who use insulin injections. The goal is to see if the CGM helps people spend more time with blood sugar in the target range of 70-180 mg/dL. Partic…

This study tests a new drug combination called Madalena association for people with type 2 diabetes whose blood sugar is not well controlled with two other diabetes medicines. About 270 adults will receive either the new combination or a placebo to see if it safely lowers HbA1c l…

This study observes 500 adults in South Korea with chronic kidney disease and type 2 diabetes who are starting finerenone as part of their routine care. Researchers will collect data on patient characteristics, treatment patterns, and side effects over up to 12 months. The goal i…

This study tests a new procedure that uses radiofrequency (RF) vapor to treat a small part of the upper intestine in people with type 2 diabetes. The goal is to see if it safely improves blood sugar control. About 20 adults with stable diabetes will be treated and followed for 6 …

This study tests an experimental cell therapy called REACT (rilparencel) in 685 adults with type 2 diabetes and chronic kidney disease. Participants receive up to two injections of their own kidney cells or a sham procedure. The goal is to see if the treatment can slow the loss o…

This early-stage study tests whether a new drug, maridebart cafraglutide, can help people with type 2 diabetes use insulin better. About 70 adults with diabetes who are already taking metformin will receive either the new drug or a placebo. The main goal is to see if the drug imp…

This study tests a new weekly injection called enicepatide to help people with obesity or overweight and type 2 diabetes lose weight. About 1,600 participants will receive either the drug or a placebo for 72 weeks. The main goal is to see how much weight they lose and if the drug…

This study checks how accurate a new glucose sensor called LabPatch is for people with type 1 or type 2 diabetes who use insulin. About 60 adults will wear the sensor for 6 hours while their blood sugar is measured and compared to standard lab tests and two commercial meters. The…

This study aims to find out how common chronic kidney disease (CKD) is in semi-rural Sub-Saharan Africa and what factors increase the risk. Researchers will follow 1,200 adults for one year, measuring kidney function and checking for conditions like diabetes, high blood pressure,…

This study is looking at whether the texture of the carotid artery wall, seen on an ultrasound, can help predict the risk of heart problems in people with type 2 diabetes. Researchers will compare 80 adults with diabetes to healthy controls, measuring artery thickness and texture…

This study looks at how certain genes might influence how well type 2 diabetes medications like exenatide work. Researchers will review medical records from 300 adults with type 2 diabetes who have taken these drugs for at least 6 months. The goal is to find patterns that could h…

This study looks at 50,000 people in Asia and the US who have chronic kidney disease and type 2 diabetes and are already taking finerenone as part of their regular care. Researchers will collect information from medical records to see how the drug is being used, who is taking it,…

This study looks at whether the standard A1C blood sugar test is accurate for people with type 2 diabetes who have a Left Ventricular Assist Device (LVAD). Researchers will compare A1C results with data from a continuous glucose monitor (CGM) worn for 3 months. The goal is to see…